Truscreen Group Ltd: 半期報告と会計
TruScreen Group Launches Five-year Cervical Screening Program in Ho Chi Minh City
New Zealand Shares Fall Ahead of Central Bank Policy Meeting; TruScreen Debuts in Vietnam
TruScreen Debuts in Vietnam With NZ$100,000 Order for Cervical Cancer Screening Devices
Truscreen Group Ltd:株主向け年次報告書
Truscreen's Fiscal Year 2024 Loss Widens
Truscreen Group Ltd:予備の最終結果
Truscreen Group Raises Additional NZ$520,000 via Share Placement; Shares Jump 5%
New Zealand Shares Jump on Friday, Fisher & Paykel Healthcare's Chair to Retire
TruScreen to Start Clinical Evaluation Trials for Cancer Screening Device
Truscreen Close to Raising NZ$500,000
New Zealand Shares Close the Week in the Green; Port of Tauranga's Fiscal H1 Revenue Falls
Truscreen's CEO Resigns
Truscreen Group to Offer Pro-Rata Renounceable Rights Issue; Shares Plunge 11%
TruScreen Secures Reimbursement Approval in Saudi Arabia for Cervical Cancer Screening Device; Shares Rise 4%
Truscreen Secures Regulatory Approval to Expand Use of Cancer Screening Device in Mexico; Shares Rise 4%
TruScreen's Nine-Month Revenue Surges 34%
New Zealand Bourse Regulator Slaps TruScreen a Fine on Audit Committee Breach
TruScreen Wins Polish Start-Up Challenge; Shares Rise 5%
New Zealand Shares Rebound on Wednesday, Air New Zealand Expects Fiscal H1 Earnings to Be on the Lower End of Guidance
データなし